Publications in collaboration with researchers from Hospital del Mar (291)

2024

  1. Adolescent cannabinoid exposure rescues phencyclidine-induced social deficits through modulation of CA2 transmission

    Progress in Neurobiology, Vol. 240

  2. Diet patterns associated with cognitive decline: methods to harmonize data from European and US cohort studies

    Frontiers in Nutrition, Vol. 11

  3. G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

    Nature communications, Vol. 15, Núm. 1, pp. 4307

  4. Glycated hemoglobin, type 2 diabetes, and poor diabetes control are positively associated with impulsivity changes in aged individuals with overweight or obesity and metabolic syndrome

    Annals of the New York Academy of Sciences, Vol. 1540, Núm. 1, pp. 211-224

  5. Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 5, pp. 1571-1583

  6. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

    Nutrition Journal, Vol. 23, Núm. 1

2023

  1. Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlate in gambling disorder

    European Psychiatry, Vol. 66, Núm. 1

  2. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity

    European Psychiatry, Vol. 66, Núm. 1

  3. Exploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity

    Molecular Psychiatry

  4. Intensive assessment of executive functions derived from performance in cognitive training games

    iScience, Vol. 26, Núm. 6

  5. Olive Oil Phenolic Compounds’ Activity against Age-Associated Cognitive Decline: Clinical and Experimental Evidence

    Antioxidants, Vol. 12, Núm. 7

  6. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1913-1924

  7. Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort

    Alzheimer's and Dementia

  8. The role of PPAR-γ in memory deficits induced by prenatal and lactation alcohol exposure in mice

    Molecular Psychiatry, Vol. 28, Núm. 8, pp. 3373-3383

  9. Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory study

    Molecular and Cellular Biochemistry

2022

  1. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

  2. Application of the Athlete Biological Passport Approach to the Detection of Growth Hormone Doping

    Journal of Clinical Endocrinology and Metabolism, Vol. 107, Núm. 3, pp. 649-659

  3. Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 47, Núm. 4, pp. 567-578

  4. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

    eLife, Vol. 11

  5. Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)-A Randomized Clinical Trial

    Current Alzheimer Research, Vol. 19, Núm. 7, pp. 541-553